Jeremy A. Scott
Lakehead University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jeremy A. Scott.
Environmental Research | 2014
Theodore Konya; Brenda Koster; Heather Maughan; M. Escobar; Meghan B. Azad; David S. Guttman; Malcolm R. Sears; Allan B. Becker; Jeffrey R. Brook; Timothy K. Takaro; Anita L. Kozyrskyj; James A. Scott; Ryan W. Allen; D. Befus; Michael Brauer; Michael M Cyr; Edith Chen; Denise Daley; Sharon D. Dell; Judah A. Denburg; Susan J. Elliott; Hartmut Grasemann; Kent T. HayGlass; Richard G. Hegele; Linn Holness; Michael S. Kobor; Tobias R. Kollmann; Catherine Laprise; Maggie Larché; Wendy Lou
The human gut is host to a diverse and abundant community of bacteria that influence health and disease susceptibility. This community develops in infancy, and its composition is strongly influenced by environmental factors, notably perinatal anthropogenic exposures such as delivery mode (Cesarean vs. vaginal) and feeding method (breast vs. formula); however, the built environment as a possible source of exposure has not been considered. Here we report on a preliminary investigation of the associations between bacteria in house dust and the nascent fecal microbiota from 20 subjects from the Canadian Healthy Infant Longitudinal Development (CHILD) Study using high-throughput sequence analysis of portions of the 16S rRNA gene. Despite significant differences between the dust and fecal microbiota revealed by Nonmetric Multidimensional Scaling (NMDS) analysis, permutation analysis confirmed that 14 bacterial OTUs representing the classes Actinobacteria (3), Bacilli (3), Clostridia (6) and Gammaproteobacteria (2) co-occurred at a significantly higher frequency in matched dust-stool pairs than in randomly permuted pairs, indicating an association between these dust and stool communities. These associations could indicate a role for the indoor environment in shaping the nascent gut microbiota, but future studies will be needed to confirm that our findings do not solely reflect a reverse pathway. Although pet ownership was strongly associated with the presence of certain genera in the dust for dogs (Agrococcus, Carnobacterium, Exiguobacterium, Herbaspirillum, Leifsonia and Neisseria) and cats (Escherichia), no clear patterns were observed in the NMDS-resolved stool community profiles as a function of pet ownership.
The Journal of Allergy and Clinical Immunology | 2013
Patricia Castellanos Penton; Xiaomin Wang; Hajera Amatullah; Josephine Cooper; Krystal J. Godri; Michelle L. North; Nivedita Khanna; Jeremy A. Scott; Chung-Wai Chow
BACKGROUNDnAsthma is a chronic inflammatory disease characterized by airways hyperresponsiveness (AHR), reversible airflow obstruction, airway remodeling, and episodic exacerbations caused by air pollutants, such as particulate matter (PM; PM <2.5 μm in diameter [PM(2.5)]) and ozone (O(3)). Spleen tyrosine kinase (Syk), an immunoregulatory kinase, has been implicated in the pathogenesis of asthma.nnnOBJECTIVEnWe sought to evaluate the effect of Syk inhibition on AHR in a chronic mouse model of allergic airways inflammation and pollutant exposure.nnnMETHODSnWe used a 12-week chronic ovalbumin (OVA) sensitization and challenge mouse model of airways inflammation followed by exposure to PM(2.5) plus O(3). Respiratory mechanics and methacholine (MCh) responsiveness were assessed by using the flexiVent system. The Syk inhibitor NVP-QAB-205 was nebulized intratracheally by using a treatment-based protocol 15 minutes before assessment of MCh responsiveness.nnnRESULTSnSyk expression increased significantly in the airway epithelia of OVA-sensitized and OVA-challenged (OVA/OVA) mice compared with OVA-sensitized but PBS-challenged (OVA/PBS) control mice. OVA/OVA mice exhibited AHR to MCh, which was attenuated by a single administration of NVP-QAB-205 (0.3 and 3 mg/kg). PM(2.5) plus O(3) significantly augmented AHR to MCh in the OVA/OVA mice, which was abrogated by NVP-QAB-205. Total inflammatory cell counts were significantly higher in the bronchoalveolar lavage fluid from OVA/OVA than OVA/PBS mice and were unaffected by PM(2.5) plus O(3) or NVP-QAB-205.nnnCONCLUSIONnNVP-QAB-205 reduced AHR and the enhanced response to PM(2.5) plus O(3) to normal levels in an established model of chronic allergic airways inflammation, suggesting that Syk inhibitors have promise as a therapy for asthma.
International Journal of Molecular Sciences | 2014
Jeremy A. Scott; MyLinh Duongh; Aaron W. Young; Padmaja Subbarao; Gail M. Gauvreau; Hartmut Grasemann
l-Arginine metabolism including the nitric oxide (NO) synthase and arginase pathways is important in the maintenance of airways function. We have previously reported that accumulation of asymmetric dimethylarginine (ADMA) in airways, resulting in changes in l-arginine metabolism, contributes to airways obstruction in asthma and cystic fibrosis. Herein, we assessed l-arginine metabolism in airways of patients with chronic obstructive pulmonary disease (COPD). Lung function testing, measurement of fractional exhaled NO (FeNO) and sputum NO metabolites, as well as quantification of l-arginine metabolites (l-arginine, l-ornithine, l-citrulline, ADMA and symmetric dimethylarginine) using liquid chromatography-mass spectrometry (LC-MS) were performed. Concentrations of l-ornithine, the product of arginase activity, correlated directly with l-arginine and ADMA sputum concentrations. FeNO correlated directly with pre- and post-bronchodilator forced expiratory volume in one second (FEV1). Sputum arginase activity correlated inversely with total NO metabolite (NOx) and nitrite concentrations in sputum, and with pre- and post-bronchodilator FEV1. These findings suggest that ADMA in COPD airways results in a functionally relevant shift of l-arginine breakdown by the NO synthases towards the arginase pathway, which contributes to airway obstruction in these patients.
The Journal of Pediatrics | 2017
Annika Klopp; Lorena Vehling; A.B. Becker; Padmaja Subbarao; Piushkumar J. Mandhane; S. E. Turvey; Diana L. Lefebvre; Malcolm R. Sears; Denise Daley; Frances Silverman; Kent T. HayGlass; Michael S. Kobor; Stuart E. Turvey; Tobias R. Kollmann; Jeffrey R. Brook; Clare D. Ramsey; Joseph Macri; Andrew J. Sandford; Peter D. Paré; Scott J. Tebbutt; Michael Brauer; Judah A. Denburg; Michael M Cyr; Anita L. Kozyrskyj; Allan B. Becker; Edith Chen; Greg Miller; Tim K. Takaro; Felix Ratjen; Hartmut Grasemann
Objective To determine whether different modes of infant feeding are associated with childhood asthma, including differentiating between direct breastfeeding and expressed breast milk. Study design We studied 3296 children in the Canadian Healthy Infant Longitudinal Development birth cohort. The primary exposure was infant feeding mode at 3 months, reported by mothers and categorized as direct breastfeeding only, breastfeeding with some expressed breast milk, breast milk and formula, or formula only. The primary outcome was asthma at 3 years of age, diagnosed by trained healthcare professionals. Results At 3 months of age, the distribution of feeding modes was 27% direct breastfeeding, 32% breastfeeding with some expressed breast milk, 26% breast milk and formula, and 15% formula only. At 3 years of age, 12% of children were diagnosed with possible or probable asthma. Compared with direct breastfeeding, any other mode of infant feeding was associated with an increased risk of asthma. These associations persisted after adjusting for maternal asthma, ethnicity, method of birth, infant sex, gestational age, and daycare attendance (some expressed breast milk: aOR, 1.64, 95% CI, 1.12‐2.39; breast milk and formula, aOR, 1.73, 95% CI, 1.17‐2.57; formula only: aOR, 2.14, 95% CI, 1.37‐3.35). Results were similar after further adjustment for total breastfeeding duration and respiratory infections. Conclusions Modes of infant feeding are associated with asthma development. Direct breastfeeding is most protective compared with formula feeding; indirect breast milk confers intermediate protection. Policies that facilitate and promote direct breastfeeding could have impact on the primary prevention of asthma.
Frontiers in Nutrition | 2017
Sarah L. Bridgman; Meghan B. Azad; Catherine J. Field; Andrea M. Haqq; Allan B. Becker; Piushkumar J. Mandhane; Padmaja Subbarao; Stuart E. Turvey; Malcolm R. Sears; James A. Scott; David S. Wishart; Anita L. Kozyrskyj; P. Subbarao; Sonia S. Anand; M. Azad; A.B. Becker; A. D. Befus; Michael Brauer; Jeffrey R. Brook; Edith Chen; Michael M Cyr; Denise Daley; Sharon D. Dell; Judah A. Denburg; Q. Duan; Thomas Eiwegger; Hartmut Grasemann; Kent T. HayGlass; Richard G. Hegele; D. L. Holness
Our gut microbiota provide a number of important functions, one of which is the metabolism of dietary fiber and other macronutrients that are undigested by the host. The main products of this fermentation process are short-chain fatty acids (SCFAs) and other intermediate metabolites including lactate and succinate. Production of these metabolites is dependent on diet and gut microbiota composition. There is increasing evidence for the role of SCFAs in host physiology and metabolic processes as well as chronic inflammatory conditions such as allergic disease and obesity. We aimed to investigate differences in fecal SCFAs and intermediate metabolites in 163 infants at 3–5u2009months of age according to breastfeeding status. Compared to no exposure to human milk at time of fecal sample collection, exclusive breastfeeding was associated with lower absolute concentrations of total SCFAs, acetate, butyrate, propionate, valerate, isobutyrate, and isovalerate, yet higher concentrations of lactate. Further, the relative proportion of acetate was higher with exclusive breastfeeding. Compared to non-breastfed infants, those exclusively breastfed were four times more likely (aOR 4.50, 95% CI 1.58–12.82) to have a higher proportion of acetate relative to other SCFAs in their gut. This association was independent of birth mode, intrapartum antibiotics, infant sex, age, recruitment site, and maternal BMI or socioeconomic status. Our study confirms that breastfeeding strongly influences the composition of fecal microbial metabolites in infancy.
Chest | 2013
Jeremy A. Scott; Hartmut Grasemann
journal.publications.chestnet.org 6. Guyatt GH , Oxman AD , Santesso N , et al . GRADE guidelines: 12. Preparing summary of fi ndings tables-binary outcomes . J Clin Epidemiol . 2013 ; 66 ( 2 ): 158 172 . 7. Guyatt GH , Thorlund K , Oxman AD , et al . GRADE guidelines: 13. Preparing summary of fi ndings tables and evidence profi les-continuous outcomes . J Clin Epidemiol . 2013 ; 66 ( 2 ): 173 183 . 8. Treweek S , Oxman AD , Alderson P , et al ; DECIDE Consortium . Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results . Implement Sci . 2013 ; 8 : 6 . 9. Guyatt G , Akl EA , Hirsh J , et al . The vexing problem of guidelines and confl ict of interest: a potential solution . Ann Intern Med . 2010 ; 152 ( 11 ): 738 741 . 10. Eisenberg JM . Globalize the evidence, localize the decision: evidence-based medicine and international diversity . Health Aff (Millwood) . 2002 ; 21 ( 3 ): 166 168 . 11. Alonso-Coello P , Martínez García L , Carrasco JM , Solà I , Qureshi S , Burgers JS ; Updating Guidelines Working Group . The updating of clinical practice guidelines: insights from an international survey . Implement Sci . 2011 ; 6 : 107 . 12. Vandvik PO , Brandt L , Alonso-Coello J , et al . Creating clinical practice guidelines we can trust, use and share: a new era is imminent . Chest . 2013 ; 144 ( 2 ): 381 389 .
Frontiers in Pediatrics | 2017
Farzana Yasmin; Hein Min Tun; Theodore Konya; David S. Guttman; Radha Chari; Catherine J. Field; Allan B. Becker; Piush J. Mandhane; Stuart E. Turvey; Padmaja Subbarao; Malcolm R. Sears; Child Study Investigators; James A. Scott; Irina Dinu; Anita L. Kozyrskyj; Sonia S. Anand; Meghan B. Azad; A.B. Becker; A. D. Befus; Michael Brauer; Jeffrey R. Brook; Edith Chen; Michael M Cyr; Denise Daley; Sharon D. Dell; Judah A. Denburg; Q. Duan; Thomas Eiwegger; Hartmut Grasemann; Kent T. HayGlass
Established during infancy, our complex gut microbial community is shaped by medical interventions and societal preferences, such as cesarean section, formula feeding, and antibiotic use. We undertook this study to apply the significance analysis of microarrays (SAM) method to quantify changes in gut microbial composition during later infancy following the most common birth and postnatal exposures affecting infant gut microbial composition. Gut microbiota of 166 full-term infants in the Canadian Healthy Infant Longitudinal Development birth cohort were profiled using 16S high-throughput gene sequencing. Infants were placed into groups according to mutually exclusive combinations of birth mode (vaginal/cesarean birth), breastfeeding status (yes/no), and antibiotic use (yes/no) by 3u2009months of age. Based on repeated permutations of data and adjustment for the false discovery rate, the SAM statistic identified statistically significant changes in gut microbial abundance between 3u2009months and 1u2009year of age within each infant group. We observed well-known patterns of microbial phyla succession in later infancy (declining Proteobacteria; increasing Firmicutes and Bacteroidetes) following vaginal birth, breastfeeding, and no antibiotic exposure. Genus Lactobacillus, Roseburia, and Faecalibacterium species appeared in the top 10 increases to microbial abundance in these infants. Deviations from this pattern were evident among infants with other perinatal co-exposures; notably, the largest number of microbial species with unchanged abundance was seen in gut microbiota following early cessation of breastfeeding in infants. With and without antibiotic exposure, the absence of a breast milk diet by 3u2009months of age following vaginal birth yielded a higher proportion of unchanged abundance of Bacteroidaceae and Enterobacteriaceae in later infancy, and a higher ratio of unchanged Enterobacteriaceae to Alcaligenaceae microbiota. Gut microbiota of infants born vaginally and exclusively formula fed became less enriched with family Veillonellaceae and Clostridiaceae, showed unchanging levels of Ruminococcaceae, and exhibited a greater decline in the Rikenellaceae/Bacteroidaceae ratio compared to their breastfed, vaginally delivered counterparts. These changes were also evident in cesarean-delivered infants to a lesser extent. The clinical relevance of these trajectories of microbial change is that they culminate in taxon-specific abundances in the gut microbiota of later infancy, which we and others have observed to be associated with food sensitization.
European Respiratory Journal | 2014
Jeremy A. Scott; Gail M. Gauvreau; Hartmut Grasemann
To the Editor: nnWith interest we have read the letter by Lau et al. [1] regarding circulating asymmetric dimethylarginine (ADMA) in a cohort of children with asthma from the Australian Childhood Asthma Prevention Study.nnADMA, a product of protein degradation, is an endogenous nitric oxide synthase inhibitor that has been shown to be increased in mouse models of allergic airway inflammation and to be associated with airways hyperresponsiveness in these animals [2]. ADMA has also been reported to be increased in sputum samples [2] and exhaled breath condensates [3] from paediatric patients with asthma. Increased ADMA in serum has recently been found to be associated with the severity of symptoms in late-onset asthma and obesity [4].nnLau et al. [1] found no difference in …
The Journal of Allergy and Clinical Immunology | 2017
Maxwell M. Tran; Diana L. Lefebvre; Christoffer Dharma; David Dai; Wendy Lou; Padmaja Subbarao; Allan B. Becker; Piush J. Mandhane; Stuart E. Turvey; Malcolm R. Sears; P. Subbarao; S. E. Turvey; Sonia S. Anand; Meghan B. Azad; A.B. Becker; A. D. Befus; Michael Brauer; Jeffrey R. Brook; Edith Chen; Michael M Cyr; Denise Daley; Sharon D. Dell; Judah A. Denburg; Q. Duan; Thomas Eiwegger; Hartmut Grasemann; Kent T. HayGlass; Richard G. Hegele; D. L. Holness; Perry Hystad
Background: The atopic march describes the progression from atopic dermatitis during infancy to asthma and allergic rhinitis in later childhood. In a Canadian birth cohort we investigated whether concomitant allergic sensitization enhances subsequent development of these allergic diseases at age 3 years. Methods: Children completed skin prick testing at age 1 year. Children were considered sensitized if they produced a wheal 2 mm or larger than that elicited by the negative control to any of 10 inhalant or food allergens. Children were also assessed for atopic dermatitis by using the diagnostic criteria of the UK Working Party. At age 3 years, children were assessed for asthma, allergic rhinitis, food allergy, and atopic dermatitis. Data from 2311 children were available. Results: Atopic dermatitis without allergic sensitization was not associated with an increased risk of asthma at age 3 years after adjusting for common confounders (relative risk [RR], 0.46; 95% CI, 0.11‐1.93). Conversely, atopic dermatitis with allergic sensitization increased the risk of asthma more than 7‐fold (RR, 7.04; 95% CI, 4.13‐11.99). Atopic dermatitis and allergic sensitization had significant interactions on both the additive (relative excess risk due to interaction, 5.06; 95% CI, 1.33‐11.04) and multiplicative (ratio of RRs, 5.80; 95% CI, 1.20‐27.83) scales in association with asthma risk. There was also a positive additive interaction between atopic dermatitis and allergic sensitization in their effects on food allergy risk (relative excess risk due to interaction, 15.11; 95% CI, 4.19‐35.36). Conclusions: Atopic dermatitis without concomitant allergic sensitization was not associated with an increased risk of asthma. In combination, atopic dermatitis and allergic sensitization had strong interactive effects on both asthma and food allergy risk at age 3 years.
PLOS ONE | 2017
Sepehr Salehi; Xiaomin Wang; S. Juvet; Jeremy A. Scott; Chung-Wai Chow
Background Asthma is a chronic inflammatory disease characterized by airways hyper-responsiveness (AHR), reversible airway obstruction, and airway inflammation and remodeling. We previously showed that Syk modulates methacholine-induced airways contractility in naïve mice and in mice with allergic airways inflammation. We hypothesize that Syk plays a role in the pathogenesis of AHR; this was evaluated in a chronic 8-week mouse model of house dust mite (HDM)-induced allergic airways inflammation. Methods We used the Sykflox/flox//rosa26CreERT2 conditional Syk knock-out mice to assess the role of Syk prior to HDM exposure, and treated HDM-sensitized mice with the Syk inhibitor, GSK143, to evaluate its role in established allergic airways inflammation. Respiratory mechanics and methacholine (MCh)-responsiveness were assessed using the flexiVent® system. Lungs underwent bronchoalveolar lavage to isolate inflammatory cells or were frozen for determination of gene expression in tissues. Results MCh-induced AHR was observed following HDM sensitization in the Syk-intact (Sykflox/flox) and vehicle-treated BALB/c mice. MCh responsiveness was reduced to control levels in HDM-sensitized Sykdel/del mice and in BALB/c and Sykflox/flox mice treated with GSK143. Both Sykdel/del and GSK143-treated mice mounted appropriate immune responses to HDM, with HDM-specific IgE levels that were comparable to Sykflox/flox and vehicle-treated BALB/c mice. HDM-induced increases in bronchoalveolar lavage cell counts were attenuated in both Sykdel/del and GSK143-treated mice, due primarily to decreased neutrophil recruitment. Gene expression analysis of lung tissues revealed that HDM-induced expression of IL-17 and CXCL-1 was significantly attenuated in both Sykdel/del and GSK143-treated mice. Conclusion Syk inhibitors may play a role in the management of neutrophilic asthma.